ArticleDigestive diseases and sciences2020

Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus.

Lee-Lee Lai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.